Feature | September 09, 2011 | David Fisher

MITA Works to Reduce Dose

Manufacturers remain committed to reducing medical radiation

Since the advent of computed tomography (CT) scans in the early 1970s, this technology has become increasingly critical to the standards of care.  Over the same time, manufacturers have continuously delivered innovative advances to CT technology, including reductions in medical radiation, while maintaining crisp, clear images.  

As the technology has become more accessible it has enabled us to detect disease earlier, save more lives and reduce mortality. A study released by the National Cancer Institute (NCI) demonstrates that low-dose CT scans are proven to be effective at saving lives, reducing lung cancer related deaths by as much as 20 percent in high-risk populations and by 7 percent for all mortality.

However, this technology must be carefully managed, monitored, tracked and double-checked.  The members of the Medical Imaging and Technology Alliance (MITA) are committed to further reducing medical radiation and working with all parties responsible for patient care to ensure CT technology is used properly and responsibly.

Manufacturers have a long history of reducing radiation dose via new hardware and software innovations.  This past year, manufacturers introduced a new CT Dose Check Initiative, an industry-wide commitment that new CT products will include additional radiation safeguards: a new radiation dose notification and dose alert features that can help reduce radiation dose and medical errors. Additionally, a new dose recording feature will track dose levels to help providers understand how their facility compares to local and national standards.  CT manufacturers have already begun shipping equipment with these new features.

In June 2010 MITA, along with the Advanced Medical Technology Association (AdvaMed), also rolled out the Radiation Therapy Readiness Check Initiative, which further enhances the safety of radiation therapy equipment through the development and implementation of additional patient protection features. These features verify that patient treatment plans are delivered as intended, and that radiation therapy equipment, accessories and patients are properly positioned prior to delivery of therapy.

Such innovations build on a long history of industry efforts to advance patient safety measures — including equipment safety standards, protocol development, quality and safety checks, provider education programs and physician-developed medical guidelines — to minimize radiation dose as much as possible and to provide even greater degrees of coordination, transparency and reporting in the delivery of medical radiation.

MITA members continue to incorporate the radiation dose management and optimization principle, As Low As Reasonably Achievable (ALARA), into all imaging procedures and technologies.  We also collaborate with other stakeholders in the medical community on related initiatives, such as the Image Gently campaign, aimed at raising awareness of the opportunities to lower radiation dose in the imaging of children. Moreover, MITA is also on the record as a staunch supporter of certification of equipment operators, accreditation of imaging facilities, uniform dose recording standards for imaging data and standardized reporting of medical errors associated with imaging and radiation therapy equipment.

Manufacturers’ proactive efforts to reduce radiation dose while continuing to improve image quality and effectiveness are an important medical success story. These innovative and life-saving technologies are allowing doctors to detect, diagnose and treat patients earlier than ever before, saving and improving millions of lives.  A National Bureau of Economic Research study revealed that cancer imaging innovation accounted for 40 percent of the reduction in U.S. cancer deaths between 1996 and 2006, which makes it most likely the largest single contributor to decreased cancer mortality during this decade.

Imaging manufacturers remain true to our pledge to ensure all patients have access to the right scan – with the right radiation dose – at the right time, and will continue to do our part to ensure every imaging procedure is both safe and medically appropriate for the patient’s condition.  We look forward to continuing to work with fellow industry stakeholders, the U.S. Food and Drug Administration and patients to further reduce unnecessary radiation exposure from medical imaging.

Dave Fisher is the executive director of the Medical Imaging and Technology Alliance (MITA), a division of NEMA, the Association for Electrical and Medical Imaging Manufacturers, which is the collective voice of medical imaging and therapy equipment manufacturers, innovators and product developers. For more information: www.medicalimaging.org

Related Content

Medic Vision, SafeCT-29, NEMA XR-29, Smart Dose, computed tomography
Technology | Computed Tomography (CT) | May 31, 2016
Medic Vision Imaging Solutions Ltd. announced the U.S. Food and Drug Administration (FDA) clearance of SafeCT-29 to...
ACR, American College of Radiology, Appropriateness Criteria update
Technology | Clinical Decision Support | May 31, 2016
The American College of Radiology (ACR) released eight new and 15 updated Appropriateness Criteria, which define...
Toshiba, Infinix 4-D CT, first U.S. install, Arkansas cancer center
News | CT Angiography (CTA) | May 26, 2016
Cancer patients at the Carti Cancer Center, Conway, Ark., now have access to the latest innovation in diagnostic...
China, computed bioconductance, CB, PET, positron emission tomography, lung lesions
News | PET Imaging | May 25, 2016
Positron emission tomography (PET) is used commonly in the diagnosis of suspected lung cancer. Computed bioconductance...
Ampronix, simulated procedures, virtual reality, medical education
News | Simulators | May 25, 2016
​​​​​​​In a new report, Ampronix looks at the rapid expansion of simulated procedures into medical education, including...
News | Oncology Diagnostics | May 25, 2016
Scientists are developing a new photonics device that listens to light and could be capable of detecting skin cancer...
3d printing, conjoined twins

A 3-D printed model of conjoined twins that was used to help guide surgeons to plan a separation procedure and help navigate the anatomy once in surgery. This case was late-breaking news highlighted at RSNA 2015.

Feature | 3-D Printing | May 24, 2016 | Dave Fornell
Science fiction offers a lot of ideas for creating new body parts on demand, and the advancement of 3-D printing (als
Carestream, OnSight 3-D Extremity System, CBCT, AAOE 2016 meeting, orthopedic imaging
News | Computed Tomography (CT) | May 24, 2016
Carestream representatives will describe the benefits of its Carestream OnSight 3-D Extremity System at the American...
HeartFlow, FFR-CT, ruptured coronary plaques, EMERALD study, EuroPCR 2016
News | CT Angiography (CTA) | May 23, 2016
First-in-human data presented at EuroPCR 2016 demonstrate that hemodynamic data from HeartFlow Inc. may help predict...
Technology | Advanced Visualization | May 23, 2016
May 23, 2016 — Mobius Medical Systems announced today they have received clearance from the U.S.
Overlay Init